| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/27/2001 | CN1067723C Gene Transferring system for target gene therapy of acceptor transducing |
| 06/27/2001 | CN1067722C Adenoviral vectors |
| 06/26/2001 | US6252136 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems |
| 06/26/2001 | US6252058 Genetically engineered nucleotide sequences; for the evaluation, diagnosis and treatment of tumors defects |
| 06/26/2001 | US6252051 ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor |
| 06/26/2001 | US6252046 Protein for the treatment of kidney defects |
| 06/26/2001 | US6252044 Riboflavin synthase polypeptide; for the controlled biosynthesis of riboflavin; for screening bactericides; for prevention of infection |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6251957 Preventing neutralizing antibodies; gene therapy |
| 06/26/2001 | US6251871 Administering pharmaceutical composition comprising adenoviral vector comprising promoter functional in eukaryotic cells and nucleic acid encoding p16 and buffer, solvent or diluent to mammal to inhibit tumor growth |
| 06/26/2001 | US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis |
| 06/26/2001 | US6251853 Pertussis toxin (ptx); beta-3 subunit of human g protein with not more than six wd repeat motifs; for the diagnosis of disorders, such as a disease associated with g protein dysregulation (i.e. hypertension) |
| 06/26/2001 | US6251677 Genetically engineered microorganism; for use in gene therapy |
| 06/26/2001 | US6251669 Mammalian, non-tumor derived cells which divide, express neuron-specific markers, and give rise to progeny which differentiate into neuronal cells; for transplantation in treatment of alzheimer's/parkinson's diseases |
| 06/26/2001 | US6251663 Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic diseases |
| 06/26/2001 | US6251652 Amino acid sequence from staphylococcus cystathionine gamma-lyase gene; drug screening; bactericides; bacteriostats; vaccines; antibodies |
| 06/26/2001 | US6251640 Genetically engineered virus having tata element promoter, tet operator sequence, and a gene which inhibits replication of virus when expressed; gene therapy; vaccines; viricides |
| 06/26/2001 | US6251628 Isolated nucleic acid molecules encoding Smad7 |
| 06/26/2001 | US6251627 Antigen presenting system and methods for activation of T-cells |
| 06/26/2001 | US6251599 Stabilized nucleic acid compositions and methods of preparation and use thereof |
| 06/26/2001 | US6251433 Polycationic polymers |
| 06/26/2001 | US6251407 And adjuvant selected from manganese gluconate, calcium gluconate, zinc gluconate, calcium fructoheptonate, zinc glucoheptonate, or calcium glycerophosphate and an oily phase ester of ethoxylated fatty acids; immunostimulatory |
| 06/26/2001 | US6251387 Topoisomerase I |
| 06/26/2001 | US6251384 Metastasis models using green fluorescent protein (GFP) as a marker |
| 06/26/2001 | US6251365 Magnetite monocrystals and phosphatide membranes |
| 06/26/2001 | CA2245461C Detection of conditions or diseases associated with an altered level of telomerase activity |
| 06/21/2001 | WO2001044497A2 Protein kinase regulation |
| 06/21/2001 | WO2001044484A1 Conditional replication of recombinant human adeno-virus dna carrying modified inverted terminal repeat sequences |
| 06/21/2001 | WO2001044482A2 Optimized t-dna transfer and vectors therefor |
| 06/21/2001 | WO2001044477A1 Method of enhancing immune responses to herpes simplex virus vaccine |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044465A2 Therapeutically useful synthetic oligonucleotides |
| 06/21/2001 | WO2001044458A2 Bovine immunodeficiency virus (biv) based vectors |
| 06/21/2001 | WO2001044455A2 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
| 06/21/2001 | WO2001044295A2 Agonists and antagonists of the receptor gpr19 and their use in appetite control |
| 06/21/2001 | WO2001044287A2 Novel polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044282A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/21/2001 | WO2001044281A2 Human secretin-like g-protein coupled receptor |
| 06/21/2001 | WO2001044198A1 Amphiphilic quinolylpolyamines as transfer agents for biologically active macromolecules |
| 06/21/2001 | WO2001043777A1 Complexation of rna, especially ribozymes, with polyethylenimines for the stabilization and cellular introduction thereof |
| 06/21/2001 | WO2001043763A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | WO2001043760A2 Use of ucp3 polynucleotides and polypeptides |
| 06/21/2001 | WO2001043759A2 Use of 11cby popypeptides and polynuceotides |
| 06/21/2001 | WO2001043540A2 Methods for producing transgenic animals |
| 06/21/2001 | WO2001014535A3 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 06/21/2001 | WO2001011034A3 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 06/21/2001 | WO2001010411A3 Implantable active ingredient depot |
| 06/21/2001 | WO2000078972A8 Regulation with binding cassette transporter protein abc1 |
| 06/21/2001 | WO2000055345A9 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 06/21/2001 | WO2000050595A3 Nucleic acid molecules associated with melanoma and thyroid tumors |
| 06/21/2001 | WO1998011243A9 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein |
| 06/21/2001 | WO1998010795A9 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 06/21/2001 | US20010004636 Into a mammalian parenchymal cell, by complexing a polynucleotide with a nonviral vector, amphipathic compounds, or polymer, inserting into a mammalian vessel, increasing the permeability of the vessel; use in gene therapy |
| 06/21/2001 | DE19957889A1 New nucleic acid encoding triterpenoid-cyclase, useful for producing cyclic triterpenoids and for increasing content of polyunsaturated fatty acids in transgenic organisms |
| 06/21/2001 | CA2406678A1 Method of enhancing immune responses to herpes simplex virus vaccine |
| 06/21/2001 | CA2394840A1 Optimized t-dna transfer and vectors therefor |
| 06/21/2001 | CA2394600A1 Methods for producing transgenic animals |
| 06/21/2001 | CA2394576A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394466A1 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | CA2393808A1 Anti-cancer synthetic oligonucleotides |
| 06/21/2001 | CA2390689A1 Human lyases and associated proteins |
| 06/21/2001 | CA2390674A1 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 06/21/2001 | CA2390662A1 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/20/2001 | EP1109021A1 Snail, new tumoral progression marker and target protein of new antitumoral compounds |
| 06/20/2001 | EP1108785A1 Apoptin-associating protein |
| 06/20/2001 | EP1108780A1 Nucleic acid sequence for potentiating the expression of useful gene and method therefor |
| 06/20/2001 | EP1108725A1 Novel polypeptide |
| 06/20/2001 | EP1108436A1 Preventives/remedies for arteriosclerosis and post-ptca reangiostenosis |
| 06/20/2001 | EP1108432A1 Method for identifying or isolating a molecule and molecules indentified thereby |
| 06/20/2001 | EP1108068A1 T-type calcium channel |
| 06/20/2001 | EP1108051A2 Inducible expression system |
| 06/20/2001 | EP1108049A2 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences |
| 06/20/2001 | EP1108048A1 Cationic complexes of polymer-modified adenovirus |
| 06/20/2001 | EP1108047A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/20/2001 | EP1108046A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 06/20/2001 | EP1108035A2 Treatment of cervical cancer |
| 06/20/2001 | EP1108034A2 Attenuated salmonella spi2 mutants as antigen carriers |
| 06/20/2001 | EP1108033A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 06/20/2001 | EP1108029A1 Kunitz domain polypeptide zkun6 |
| 06/20/2001 | EP1108028A2 Dna cancer vaccine and methods for its use |
| 06/20/2001 | EP1108026A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 06/20/2001 | EP1108025A2 Phelix: a testis-specific protein expressed in cancer |
| 06/20/2001 | EP1108023A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 06/20/2001 | EP1108021A2 Human genes differentially expressed in colorectal cancer |
| 06/20/2001 | EP1108016A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy |
| 06/20/2001 | EP1108014A1 $i(EHRLICHIA CANIS) 120-KDA IMMUNODOMINANT ANTIGENIC PROTEIN AND GENE |
| 06/20/2001 | EP1108013A2 Genes associated with neurotransmitter processing |
| 06/20/2001 | EP1108011A2 In vitro maintenance of hematopoietic stem cells |
| 06/20/2001 | EP1108008A1 Novel ubiquitin ligases as therapeutic targets |
| 06/20/2001 | EP1107992A2 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6 |
| 06/20/2001 | EP1107989A2 Expression and export of angiostatin and endostatin as immunofusins |
| 06/20/2001 | EP1107978A1 Secreted proteins and polynucleotides encoding them |
| 06/20/2001 | EP1107797A2 Hypoxia regulated genes |
| 06/20/2001 | EP1107790A1 Targeting of molecules to large vessel endothelium using epcr |
| 06/20/2001 | EP1107789A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107785A1 Method of dna vaccination |